(Q35925559)

11 August 2017

1 reference

title

Therapeutic approaches in treating Creutzfeldt-Jakob disease - what does the future hold? (English)

1 reference

Creutzfeldt-Jakob disease

11 August 2017

main subject

1 reference

Esther A Croes

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

2391-2396

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

11 August 2017

1 reference

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

A new variant of Creutzfeldt-Jakob disease in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Porphyrin and phthalocyanine antiscrapie compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Potent inhibition of scrapie-associated PrP accumulation by congo red

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Chemoprophylaxis of scrapie in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Sulphate polyanions prolong the incubation period of scrapie-infected hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Drug therapy in human and experimental transmissible spongiform encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Postexposure prophylaxis against prion disease with a stimulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Tetracyclines affect prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Small drugs lead the attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2391

10.1517/14656566.5.11.2391

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference